Le Lézard
Classified in: Health
Subjects: CHI, PER, SVY

Rady Children's Appoints Praveen Raju, MD, PhD, as the Nathan Gordon Chair and Medical Director of Neuro-Oncology Program


SAN DIEGO, April 2, 2024 /PRNewswire/ -- Rady Children's Hospital-San Diego, one of the nation's top pediatric health care systems, and the University of California San Diego are pleased to announce that Praveen Raju, MD, PhD, will be appointed as Medical Director, Pediatric Neuro-Oncology Program, Rady Children's Hospital-San Diego; and Director, Pediatric Neuro-Oncology Program, and Associate Physician Diplomate, Neurosciences, at UC San Diego School of Medicine. At Rady Children's, Dr. Raju has also been named the Nathan Gordon Chair in Neuro-Oncology, established in 2021 to honor the memory of Nathan Gordon, who was diagnosed with a rare tumor in his spinal cord when he was just 15 months old. As part of Rady Children's nationally recognized care team, Dr. Raju will spearhead the growth of the Neuro-Oncology Program and advance research efforts on pediatric brain and spinal tumors. 

By incorporating subspecialty expertise, Dr. Raju aims to address different forms of pediatric brain and spinal tumors.

By incorporating subspecialty expertise into the Neuro-Oncology Program, Dr. Raju aims to address the different forms and distinct molecular subtypes of pediatric brain and spinal tumors. Coming to Rady Children's from Mount Sinai Kravis Children's Hospital, he previously worked as a pediatric neurologist and directed the Laboratory for Pediatric Brain Tumor Research at the Icahn School of Medicine as well as established the Children's Brain and Spinal Tumor Center at that institution. His research focuses on studying the developmental origins of medulloblastoma and other pediatric brain tumors in addition to advancing novel drug delivery strategies that enhance treatment efficacy and minimize the toxicities that can impact the developing child.

"Neuro-oncology is a specialty that overlaps with many departments. From my perspective, entering the operating room equipped with relevant, up-to-date research is nonnegotiable, especially when operating on complex central nervous system tumors. To have a skilled physician on staff focused on undertaking this critical research is vital." said Michael Levy, MD, PhD, Chief of Pediatric Neurosurgery at Rady Children's and clinical professor of neurological surgery at UC San Diego School of Medicine. "We are thrilled to welcome Dr. Raju, an experienced clinician-scientist in child neurology, to lead research efforts through our growing Neuro-Oncology Program." 

The Rady Children's Neuro-Oncology Program is the only program in the San Diego region providing comprehensive care to more than 750 children and young adults with brain and spinal cord tumors. The multidisciplinary team ? which works closely with Rady Children's Institute for Genomic Medicine for diagnosis and treatment ? is leading the way in personalizing therapy based on the molecular and functional characteristics of each patient's tumor, resulting in improved outcomes for children with these devastating diseases.  

"Pediatric brain and spinal tumors can be difficult to diagnose at times and often have poor outcomes. I chose this specialty because I wanted to change those outcomes and give families hope," said Dr. Raju, who is board certified in neurology with special qualifications in child neurology. "Research will be the foundation of this advancement, yet current studies often do not address the translational hurdles that limit bridging exciting laboratory findings with clinical care. Through increased collaboration with the biotechnology industry in San Diego, I'm optimistic that we can dramatically improve patient care." 

"Unfortunately, brain and spinal tumors are the leading cause of cancer-related death in children thus emphasizing the unmet need in this area. Dr. Raju's focus on investigative research into the perplexing origins of medulloblastomas is critical for changing the outcomes of pediatric patients," said William Roberts, MD, Medical Director of Hematology/Oncology at the Peckham Center for Cancer & Blood Disorders at Rady Children's and clinical professor of pediatrics at UC San Diego School of Medicine "I look forward to the advancement of his research and the undoubtedly positive impact it will have on the patients at Rady Children's." 

Dr. Raju obtained his medical degree from the University of Pennsylvania School of Medicine, where he also earned his doctorate in cell and molecular biology and genetics as an NIH-funded MSTP fellow. He completed his residency in pediatrics at Babies & Children's Hospital of New York and subsequently finished his pediatric neurology training at Boston Children's Hospital. Prior to establishing his independent research program, he completed additional research fellowship training as part of the NIH-funded Pediatric Scientist Development Program at Memorial Sloan Kettering Cancer Center.

Media contact:
Carlos Delgado
[email protected]
(619) 261-8392 

SOURCE Rady Children's Hospital-San Diego


These press releases may also interest you

at 05:23
The revenue in June for Zinzino's sales markets increased by 13% and amounted to SEK 148.5 (131.4) million. Faun Pharma's external sales decreased and amounted to SEK 5.8 (8.5) million. Overall, the Group increased revenues by 10% to SEK 154.3...

at 05:00
The global Specialty Enzymes Market size is estimated to be valued at USD 6.1 billion in 2024 and is projected to reach USD 9.2 billion by 2029, recording a CAGR of 8.5% from 2024 to 2029 according to a report published by MarketsandMarketstm. The...

at 05:00
Kvantify, a leading quantum software start-up, has announced the successful closure of a EUR 10 million seed round. This funding will enable Kvantify to strengthen its position as a global leader in quantum computing, with an initial focus on...

at 04:37
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cytotoxic Drugs and HPAPI Manufacturing  Market- (Type of Product (HPAPI and highly potent finished dosage form), Company Size (Small, Mid-sized, Large,...

at 04:32
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Direct Primary Care Market"- By Type (Clinical Services, Telehealth Services, Laboratory Services, Consultative Services), Care Setting (Office-Based DPC...

at 04:32
The Compound Annual Growth Rate (CAGR) measures how much an investment grows each year, on average, over a period. It helps to show the overall trend by smoothing out the ups and downs. Recently, BCC Research predicted that a certain industry would...



News published on and distributed by: